Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    7539701 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
Conditions: Asthenia;   Neoplasms
Interventions: Drug: methylphenidate;   Drug: placebo comparator

Indicates status has not been verified in more than two years